Cargando…

Efficacy of Gemfibrozil as an Adjunct to Sertraline in Major Depressive Disorder, A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial

Objective: Major depressive disorder (MDD) is predicted to be one of the biggest disease burden in the future. The antidepressant activity of gemfibrozil has been recently considered. In this study, we assessed the effectiveness of gemfibrozil as a sertraline adjunct in treating patients with MDD. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zandifar, Atefeh, Badrfam, Rahim, Shamabadi, Ahmad, Jalilevand, Shakiba, Pourmirbabaei, Shayan, Torkamand, Farbod, Sahebolzamani, Erfan, Akhondzadeh, Shahin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Psychiatry & Psychology Research Center, Tehran University of Medical Sciences 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140300/ https://www.ncbi.nlm.nih.gov/pubmed/34054983 http://dx.doi.org/10.18502/ijps.v16i1.5379

Ejemplares similares

Efficacy of Spironolactone as an Adjunctive Therapy to Risperidone to Improve Symptoms of Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled, Clinical Trial
por: Zandifar, Atefeh, et al.
Publicado: (2022)

The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double‐blind, randomized, placebo‐controlled, clinical trial
por: Badrfam, Rahim, et al.
Publicado: (2021)

Asia and COVID-19; The need to continue mental health care to prevent the spread of suicide in the elderly
por: Badrfam, Rahim, et al.
Publicado: (2020)

From encephalitis lethargica to COVID-19: Is there another epidemic ahead?
por: Badrfam, Rahim, et al.
Publicado: (2020)

COVID-19 and Melancholia: Different Perception of the Concept of Stigma and Loss
por: Badrfam, Rahim, et al.
Publicado: (2020)

Stigma Over COVID-19; New Conception Beyond Individual Sense
por: Badrfam, Rahim, et al.
Publicado: (2020)

COVID-19 and mental health: An Iranian perspective
por: Badrfam, Rahim, et al.
Publicado: (2020)

Iranian mental health during the COVID-19 epidemic
por: Zandifar, Atefeh, et al.
Publicado: (2020)

COVID-19: Considering the prevalence of schizophrenia in the coming decades
por: Zandifar, Atefeh, et al.
Publicado: (2020)

Mental Health of Medical Workers in COVID-19 Pandemic: Restrictions and Barriers
por: Badrfam, Rahim, et al.
Publicado: (2020)

Status of stigma on the health care workers related to COVID-19 at the first wave of the pandemic in Iran: A qualitative study
por: Badrfam, Rahim, et al.
Publicado: (2022)

Low-Dose Quetiapine in the Treatment of SSRI-Induced Bruxism and Mandibular Dystonia: Case Series
por: Zandifar, Atefeh, et al.
Publicado: (2018)

Mental Health Care for Medical Staff in Iran during the COVID-19 Pandemic; Different Performance in Alborz Province
por: Zandifar, Atefeh, et al.
Publicado: (2020)

Creutzfeldt-Jakob Disease after Dental Procedure along with the Initial Manifestations of Psychiatric Disorder: A Case Report
por: Badrfam, Rahim, et al.
Publicado: (2021)

Suicidal ideation, burnout, and their correlation among health care workers at the end of the fourth wave of the COVID-19 pandemic in Alborz Province, Iran
por: Badrfam, Rahim, et al.
Publicado: (2023)

Anti N‐Methyl‐D‐Aspartate (NMDA) receptor encephalitis: from psychosis to cognitive impairment
por: Vahabi, Zahra, et al.
Publicado: (2021)

Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial
por: Akhondzadeh, Shahin, et al.
Publicado: (2003)

Comorbidity of adult ADHD and substance use disorder in a sample of inpatients bipolar disorder in Iran
por: Badrfam, Rahim, et al.
Publicado: (2022)

Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial
por: Rezaei, Farzin, et al.
Publicado: (2015)

Crocus sativus (saffron) in the treatment of female sexual dysfunction: a three-center, double-blind, randomized, and placebo-controlled clinical trial
por: Kashani, Ladan, et al.
Publicado: (2022)

Basic Science and Clinical Studies on Non-COVID-19 Topics, of Coronavirus Victims
por: Akhondzadeh, Shahin, et al.
Publicado: (2021)

Medical Biotechnology in the Service of Coronavirus Vaccine Discovery and Production
por: Akhondzadeh, Shahin, et al.
Publicado: (2021)

Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction due to Attenuated Pathogenicity and Booster Vaccine Doses
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

Protection against the Omicron and Subsequent Coronavirus Variants: Medical-grade Masking, Third Dose Vaccination, Updating Vaccines, and Pursuing Universal Vaccine
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

The Requisiteness for not Sacrificing Medical Biotechnology in the Coronavirus Era
por: Akhondzadeh, Shahin, et al.
Publicado: (2021)

Monkeypox Outbreaks in Non-Endemic Countries: What Do We Know and What Do We Need?
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

Inflammation-Schizophrenia: A Bidirectional Causal Association Mediated by Cytokines
por: Shamabadi, Ahmad, et al.
Publicado: (2023)

Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial
por: Samaei, Areoo, et al.
Publicado: (2020)

Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial
por: Kianimehr, Gilda, et al.
Publicado: (2014)

Prevalence and Associated Factors of Posttraumatic Stress Symptoms and Stigma among Health Care Workers in Contact with COVID-19 Patients
por: Zandifar, Atefeh, et al.
Publicado: (2020)

Integrating Psychiatry and Medical Biotechnology as a Way to Achieve Scientific, Precision, and Personalized Psychiatry
por: Shamabadi, Ahmad, et al.
Publicado: (2021)

The neuropsychotropic effects of Crocus sativus L. (saffron): an overview of systematic reviews and meta-analyses investigating its clinical efficacy in psychiatric and neurological disorders
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

Femicomfort in the Treatment of Premenstrual Syndromes: A Double-Blind, Randomized and Placebo Controlled Trial
por: Kashani, Ladan, et al.
Publicado: (2010)

Acetaminophen as Adjuvant to Risperidone in Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Arabzadeh, Somaye, et al.
Publicado: (2018)

Bullous dermatosis of childhood induced by gemfibrozil
por: Abtahi-Naeini, Bahareh, et al.
Publicado: (2015)

Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial [ISRCTN64132371]
por: Akhondzadeh, Shahin, et al.
Publicado: (2004)

Coronavirus disease 2019 in Iran: the need for more attention to primary health care
por: Badrfam, R., et al.
Publicado: (2020)

Prevalence and severity of depression, anxiety, stress and perceived stress in hospitalized patients with COVID-19
por: Zandifar, Atefeh, et al.
Publicado: (2020)

Oxybutynin reduces sweating in depressed patients treated with sertraline: a double-blind, placebo-controlled, clinical study
por: Ghaleiha, Ali, et al.
Publicado: (2012)

Effect of Sertraline on Uremic Pruritus Improvement in ESRD Patients
por: Shakiba, Mansor, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_nn375vtmt8pmdgsvk323hug054